跳至主要内容
临床试验/TCTR20210304002
TCTR20210304002已完成3 期

Effect of Smartphone-assisted Lifestyle Modification Intervention in MAFLD Patients: A Randomized Controlled Trial

Faculty of Medicine, Prince of Songkla University0 个研究点目标入组 122 人开始时间: 2021年3月4日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
122

研究概览

简要总结

Encouraging LSI and delivering MAFLD information via a social media application (LINE official account) to patients with MAFLD demonstrated a better outcome of liver stiffness measurement than SOC.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Hepatic steatosis diagnosed by imaging techniques or histology within 1 year before screening AND met the definition of MAFLD according to international consensus 2020, 2. Patients are smartphone users with LINE application installed in their smartphones, and use LINE application regularly in daily life, 3. In patients with diabetes mellitus type 2, and/or dyslipidemia, the dosage of medications to treat diabetes and dyslipidemia is stable for at least 3 months

排除标准

  • 1. Ongoing treatment with Thiazolidinedione and GLP1 group in type 2 diabetic patients, tamoxifen in breast cancer patients., 2. Coexisted with any active malignancies (with or without treatment), 3. Previous treatment of any malignancies within 6 months., 4. Significant of alcohol consumption (greater than or equal to 21 standard drinks per week in male and greater than or equal to 14 standard drink in female), 5. Concomitant infection or liver disease, which has exact treatment, such as chronic hepatitis B, chronic hepatitis C, autoimmune hepatitis, Wilson(s) disease, 6. Cirrhosis evidence from imaging techniques or histology or LSM more than 17 kPa, 7. Unstable cardiovascular/ cerebrovascular/ pulmonary conditions e.g. recent myocardial infarction or COPD exacerbation within 1 year, 8. Patients unwilling to participate in the study, 9. Pregnancy, 10. Conditions which make unreliable VCTE result

研究者

发起方
Faculty of Medicine, Prince of Songkla University

相似试验